AHA Satellite Symposium: "Can We Really Grow New Blood Vessels?"

Marketing Postcard Image


Pre-registration for this FREE symposium is available at the top of this page.


Symposium Description

Therapeutic angiogenesis is a novel approach to the treatment of refractory angina (RA) and critical limb ischemia (CLI). The goal of therapy is to enhance the natural process of collateral blood vessel growth through the use of growth factors, genes which encode or stem cells. Our goal is to review the natural history of RA and CLI and to discuss current approaches to therapeutic angiogenesis.

Learning Objectives

After attending this symposium, participants will be able to:

  • Describe the natural history and prevalence of refractory angina (RA) and critical limb ischemia (CLI).
  • Discuss the current available clinical and research options for RA and CLI, including revascularization, pharmacological, cell and angiogenic therapies.
  • Explain the rationale and trial results of cell and angiogenic therapies in RA and CLI.


Target Audience

Attendees of the American Heart Association Scientific Sessions and other interested health care professionals.



This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Minnesota and Minneapolis Heart Institute Foundation. The University of Minnesota is accredited by the ACCME to provide continuing medical education for physicians.

The University of Minnesota designates this educational activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, nurses, and other health care professionals who participate in this CME activity may submit their Statements of Attendance to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.


Acknowledgement of Support

This CME program is supported by unrestricted educational grants from Aastrom Biosciences, Inc.; Baxter International, Inc.; Biosense Webster, Inc.; Cardiogenesis Corporation; and Sanofi-Aventis U.S.


Agenda on Sunday, November 15, 2009


Registration, Dinner Begins


Welcome and Introductions — Timothy Henry, Minneapolis Heart Institute Foundation


Refractory Angina: Frequency, Natural History, Available Options — Timothy Henry, Minneapolis Heart Institute Foundation


Critical Limb Ischemia: Epidemiology, Risk, Cost and Options — Alan Hirsch, Minneapolis Heart Institute




Case Presentation: Refractory Angina


CD34+ Stem Cells for Refractory Chronic Myocardial Ischemia (ACT34-CMI) — Douglas Losordo, Northwestern Memorial Hospital


Transmyocardial revasularization (TMR) and Stem Cell Therapy for Refractory Angina — Christopher White, Ochsner Clinic Foundation




Case Presentation: Critical Limb Ischemia — Subhash Thakur, Jobst Vascular Center


Gene Therapy for CLI — Sigrid Nikol, Askelpios Klinik St. Georg, Hamburg, Germany


Stem Cell Therapy for CLI — Timothy Henry, Minneapolis Heart Institute Foundation




Closing Remarks and Adjournment



Timothy D. Henry, MD, FACC
Director of Research, Minneapolis Heart Institute Foundation
Interventional Cardiologist, Minneapolis Heart Institute
Minneapolis, Minnesota
Alan T. Hirsch, MD, FACC, FAHA
Medical Director, Abbott Northwestern Hospital's Vascular Center
Professor of Epidemiology, University of Minnesota School of Public Health
Minneapolis, Minnesota
Douglas W. Losordo, MD, FACC
Director, Feinberg Cardiovascular Research Institute and Program in Cardiovascular Regenerative Medicine
Northwestern Memorial Hospital
Chicago, Illinois
Sigrid Nikol, MD
Head of Clinical and Interventional Angiology
ASKLEPIOS Klinik St. Georg
Hamburg, Germany
Subhash Thakur, MD
Vascular Surgeon
Jobst Vascular Center
Toledo, Ohio
Jay H. Traverse, MD, FACC, FAHA
Interventional Cardiolologist, Minneapolis Heart Institute
Associate professor of Medicine, Universiyt of Minnesota School of Medicine
Minneapolis, MN

Christopher J. White, MD, FACC, FAHA
Director, Ochsner Heart and Vascular Institute
Chairman, Department of Cardiology
New Orleans, Louisiana




Disclosure Policy

The policy of both Minneapolis Heart Institute Foundation and the University of Minnesota Office of Continuing Medical Education is to ensure balance, independence, objectivity and scientific rigor in all of its sponsored educational activities. All participating speakers, course directors, and planning committee members are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. Specific disclosure information for each speaker, course director, and planning committee member will be shared with the audience at the beginning of the activity.



Pre-registration for this FREE symposium is available at the top of this page.


Name Sales End Price
Attendee Ended Free

On the Web

Abbott Northwestern Hospital Foundation Contribute To

Aha satellite symposium: "can we really grow new blood vessels?" Video Preview


Updates and Results From Aastrom's Vascular Program ...

Nov 16, 2009 · ... evening at an American Heart Association Satellite Symposium titled "Can We Really Grow New Blood Vessels ... Association Satellite Symposium ...


Cardiogenesis Corp /CA - FORM 8-K - EX-99.2 - November 12 ...

... a satellite symposium sponsored by the Minneapolis Heart Institute at the American Heart Association meeting ... “Can We Really Grow New Blood Vessels ...


Updates and Results From Aastrom's Vascular Program Presented at an American Heart Association Satellite Symposium

announced that two oral presentations regarding the Company's vascular clinical program were given Sunday evening at an American Heart Association Satellite Symposium titled "Can We Really Grow New Blood Vessels?" in Orlando, FL: * Timothy Henry ...

GlobeNewswire • 11/16/2009